GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Plandai Biotechnology Inc (OTCPK:PLPL) » Definitions » ROA %

Plandai Biotechnology (Plandai Biotechnology) ROA % : 0.00% (As of Jun. 2023)


View and export this data going back to . Start your Free Trial

What is Plandai Biotechnology ROA %?

ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. Plandai Biotechnology's annualized Net Income for the quarter that ended in Jun. 2023 was $-19.80 Mil. Plandai Biotechnology's average Total Assets over the quarter that ended in Jun. 2023 was $ 0 Mil. Therefore, Plandai Biotechnology's annualized ROA % for the quarter that ended in Jun. 2023 was Not Available.

The historical rank and industry rank for Plandai Biotechnology's ROA % or its related term are showing as below:

During the past 13 years, Plandai Biotechnology's highest ROA % was 105.80%. The lowest was -173.00%. And the median was -63.70%.

PLPL's ROA % is not ranked *
in the Diversified Financial Services industry.
Industry Median: -0.84
* Ranked among companies with meaningful ROA % only.

Plandai Biotechnology ROA % Historical Data

The historical data trend for Plandai Biotechnology's ROA % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Plandai Biotechnology ROA % Chart

Plandai Biotechnology Annual Data
Trend Mar09 Mar10 Mar11 Jun12 Jun13 Jun14 Jun15 Jun16 Jun22 Jun23
ROA %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -173.00 -108.19 -58.56 105.80 -

Plandai Biotechnology Semi-Annual Data
Mar03 Mar04 Mar05 Mar06 Mar07 Mar08 Mar09 Mar10 Mar11 Jun12 Jun13 Jun14 Jun15 Jun16 Jun22 Jun23
ROA % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -173.00 -108.19 -58.56 105.80 -

Competitive Comparison of Plandai Biotechnology's ROA %

For the Shell Companies subindustry, Plandai Biotechnology's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Plandai Biotechnology's ROA % Distribution in the Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, Plandai Biotechnology's ROA % distribution charts can be found below:

* The bar in red indicates where Plandai Biotechnology's ROA % falls into.



Plandai Biotechnology ROA % Calculation

Plandai Biotechnology's annualized ROA % for the fiscal year that ended in Jun. 2023 is calculated as:

ROA %=Net Income (A: Jun. 2023 )/( (Total Assets (A: Jun. 2022 )+Total Assets (A: Jun. 2023 ))/ count )
=-19.801/( (0+0)/ 1 )
=-19.801/0
=N/A %

Plandai Biotechnology's annualized ROA % for the quarter that ended in Jun. 2023 is calculated as:

ROA %=Net Income (Q: Jun. 2023 )/( (Total Assets (Q: Jun. 2022 )+Total Assets (Q: Jun. 2023 ))/ count )
=-19.801/( (0+0)/ 1 )
=-19.801/0
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Net Income data used here is one times the annual (Jun. 2023) net income data. ROA % is displayed in the 30-year financial page.


Plandai Biotechnology  (OTCPK:PLPL) ROA % Explanation

ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A bank’s ROA % is typically well under 2%.

Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:

ROA %(Q: Jun. 2023 )
=Net Income/Total Assets
=-19.801/0
=(Net Income / Revenue)*(Revenue / Total Assets)
=(-19.801 / 0)*(0 / 0)
=Net Margin %*Asset Turnover
=N/A %*N/A
=N/A %

Note: The Net Income data used here is one times the annual (Jun. 2023) net income data. The Revenue data used here is one times the annual (Jun. 2023) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).

Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.

E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.


Plandai Biotechnology ROA % Related Terms

Thank you for viewing the detailed overview of Plandai Biotechnology's ROA % provided by GuruFocus.com. Please click on the following links to see related term pages.


Plandai Biotechnology (Plandai Biotechnology) Business Description

Traded in Other Exchanges
N/A
Address
4811 49th Street, San Diego, CA, USA, 92115
Plandai Biotechnology Inc. manufactures highly bioavailable extracts from live plant materials.
Executives
Callum Baylis-duffield director FLAT 37 ISLAND HOUSE THREE MILL LANE, LONDON ENGLAND X0 E33AF
Timothy Matula other: Former Director 175 JACKSON AVE N, SUITE 102, MINNEAPOLIS MN 55343
Brian Johnson director P.O. BOX 1594, FERNDALE WA 98248-1594
Roger Duffield director, officer: President, Secretary and CFO 2226 EASTLAKE AVENUE EAST #156, SEATTLE WA 98102
Daron Baylis Duffield director 2226 EASTLAKE AVENUE EAST #156, SEATTLE WA 98102
David Rzepnicki director 21 HORIZON DRIVE, SARATOGA SPRINGS NY 12866